| 1317 |
6-MONTH RESULTS OF THE LEVANT I TRIAL: A Comparison of the Moxy™ Drug Coated Balloon Catheter vs. Standard PTA for Femoropopliteal Disease |
|
Oct. 18. 10 |
| 1316 |
Two-Year Outcomes After Everolimus-or Sirolimus-Eluting Stents in Patients With Coronary Artery Diseasein the ISAR-TEST 4 Trial |
|
Oct. 18. 10 |
| 1315 |
A Prospective, Multicenter Randomized Trial of Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin, and Drug-eluting vs. Bare Metal Stents in ST-Segment Elevation Myocardial Infarction: Final Reportfrom the HORIZONS-AMI Trial |
|
Oct. 18. 10 |
| 1314 |
EXCELLENT: Efficacy of Xience/Promus versus Cypherto rEduce Late Loss in stent |
|
Oct. 18. 10 |
| 1313 |
DES-BTK: A Prospective, Double-Blind Randomized Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease |
|
Oct. 18. 10 |
| 1312 |
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents |
|
Oct. 18. 10 |
| 1311 |
Compare Trial: 2 year follow-up |
|
Oct. 18. 10 |
| 1310 |
The BLAST Trial: Biorest Liposomal Alendronate with Stenting sTudy |
|
Oct. 18. 10 |
| 1309 |
BioFreedom: A Prospective Randomized Trial of Polymer-Free BiolimusA9-Eluting Stents and Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease |
|
Oct. 18. 10 |
| 1308 |
AVIO: A Prospective, Randomized Trial of Intravascular-Ultrasound Guided Compared to Angiography Guided Stent Implantation in Complex Coronary Lesions |
|
Oct. 18. 10 |
